Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

GRADE guidelines: 22. The GRADE approach for tests and strategies-from test accuracy to patient-important outcomes and recommendations.

Schünemann HJ, Mustafa RA, Brozek J, Santesso N, Bossuyt PM, Steingart KR, Leeflang M, Lange S, Trenti T, Langendam M, Scholten R, Hooft L, Murad MH, Jaeschke R, Rutjes A, Singh J, Helfand M, Glasziou P, Arevalo-Rodriguez I, Akl EA, Deeks JJ, Guyatt GH; GRADE Working Group.

J Clin Epidemiol. 2019 Feb 7. pii: S0895-4356(17)31095-8. doi: 10.1016/j.jclinepi.2019.02.003. [Epub ahead of print]

PMID:
30738926
2.

Grading the GRADE-Critical Care Community and Trustworthy Guidelines.

Alhazzani W, Belly-Cote E, Jaeschke R.

Crit Care Med. 2019 Jan;47(1):142-144. doi: 10.1097/CCM.0000000000003529. No abstract available.

PMID:
30557251
3.

Conflicts of interest disclosure forms and management in critical care clinical practice guidelines.

Alhazzani W, Lewis K, Jaeschke R, Rochwerg B, Møller MH, Evans L, Wilson KC, Patel S, Coopersmith CM, Cecconi M, Guyatt G, Akl EA.

Intensive Care Med. 2018 Oct;44(10):1691-1698. doi: 10.1007/s00134-018-5367-6. Epub 2018 Sep 27. Review.

PMID:
30264380
4.

Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.

Chu DK, Kim LH, Young PJ, Zamiri N, Almenawer SA, Jaeschke R, Szczeklik W, Schünemann HJ, Neary JD, Alhazzani W.

Lancet. 2018 Apr 28;391(10131):1693-1705. doi: 10.1016/S0140-6736(18)30479-3. Epub 2018 Apr 26. Review.

PMID:
29726345
5.

Are systematic reviews and meta-analyses still useful research? Yes.

Annane D, Jaeschke R, Guyatt G.

Intensive Care Med. 2018 Apr;44(4):512-514. doi: 10.1007/s00134-018-5102-3. Epub 2018 Apr 16. No abstract available.

PMID:
29663046
6.

Chloride and Other Electrolyte Concentrations in Commonly Available 5% Albumin Products.

Lai AT, Zeller MP, Millen T, Kavsak P, Szczeklik W, Elahie A, Alhazzani W, D'Aragon F, Jaeschke R, Lamontagne F, Karachi T, Cook D, Meade M, Rochwerg B; Canadian Critical Care Trials Group.

Crit Care Med. 2018 Apr;46(4):e326-e329. doi: 10.1097/CCM.0000000000002955.

PMID:
29293151
7.

Correction to: Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials.

Alhazzani W, Alshamsi F, Belley-Cote E, Heels-Ansdell D, Brignardello-Petersen R, Alquraini M, Perner A, Møller MH, Krag M, Almenawer S, Rochwerg B, Dionne J, Jaeschke R, Alshahrani M, Deane A, Perri D, Thebane L, Al-Omari A, Finfer S, Cook D, Guyatt G.

Intensive Care Med. 2018 Feb;44(2):277-278. doi: 10.1007/s00134-017-5023-6.

PMID:
29230521
8.

Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis.

Nath S, Koziarz A, Badhiwala JH, Alhazzani W, Jaeschke R, Sharma S, Banfield L, Shoamanesh A, Singh S, Nassiri F, Oczkowski W, Belley-Côté E, Truant R, Reddy K, Meade MO, Farrokhyar F, Bala MM, Alshamsi F, Krag M, Etxeandia-Ikobaltzeta I, Kunz R, Nishida O, Matouk C, Selim M, Rhodes A, Hawryluk G, Almenawer SA.

Lancet. 2018 Mar 24;391(10126):1197-1204. doi: 10.1016/S0140-6736(17)32451-0. Epub 2017 Dec 7. Review.

PMID:
29223694
9.

Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials.

Alhazzani W, Alshamsi F, Belley-Cote E, Heels-Ansdell D, Brignardello-Petersen R, Alquraini M, Perner A, Møller MH, Krag M, Almenawer S, Rochwerg B, Dionne J, Jaeschke R, Alshahrani M, Deane A, Perri D, Thebane L, Al-Omari A, Finfer S, Cook D, Guyatt G.

Intensive Care Med. 2018 Jan;44(1):1-11. doi: 10.1007/s00134-017-5005-8. Epub 2017 Dec 4. Erratum in: Intensive Care Med. 2017 Dec 11;:.

10.

Prophylactic Endotracheal Intubation in Patients with Upper Gastrointestinal Bleeding Undergoing Endoscopy: A Systematic Review and Meta-analysis.

Alshamsi F, Jaeschke R, Baw B, Alhazzani W.

Saudi J Med Med Sci. 2017 Sep-Dec;5(3):201-209. doi: 10.4103/sjmms.sjmms_95_17. Epub 2017 Aug 21. Review.

11.

Fluids in Sepsis and Septic Shock (FISSH): protocol for a pilot randomised controlled trial.

Rochwerg B, Millen T, Austin P, Zeller M, D'Aragon F, Jaeschke R, Masse MH, Mehta S, Lamontagne F, Meade M, Guyatt G, Cook DJ; Canadian Critical Care Trials Group.

BMJ Open. 2017 Jul 20;7(7):e017602. doi: 10.1136/bmjopen-2017-017602.

12.

Treatment of hypertension: When to start? What is the target? Dr. Franz H. Messerli in an interview with Dr. Roman Jaeschke: part 2.

Messerli FH, Jaeschke R.

Pol Arch Intern Med. 2017 Mar 31;127(3):221-222. doi: 10.20452/pamw.3993. Epub 2017 Mar 31. No abstract available.

13.

Treatment of hypertension: choosing the first‑line treatment. Dr. Franz H. Messerli in an interview with Dr. Roman Jaeschke: part 1.

Messerli FH, Jaeschke R.

Pol Arch Intern Med. 2017 Mar 31;127(3):219-220. doi: 10.20452/pamw.3992. Epub 2017 Mar 31. No abstract available.

14.

Sucralfate versus histamine 2 receptor antagonists for stress ulcer prophylaxis in adult critically ill patients: A meta-analysis and trial sequential analysis of randomized trials.

Alquraini M, Alshamsi F, Møller MH, Belley-Cote E, Almenawer S, Jaeschke R, MacLaren R, Alhazzani W.

J Crit Care. 2017 Aug;40:21-30. doi: 10.1016/j.jcrc.2017.03.005. Epub 2017 Mar 8. Review.

PMID:
28315586
15.

Microbiome: fecal transplant in Clostridium difficile and ulcerative colitis. Dr. Paul Moayyedi in an interview with Dr. Roman Jaeschke: part 2.

Moayyedi P, Jaeschke R.

Pol Arch Intern Med. 2017 Feb 28;127(2):137-138. doi: 10.20452/pamw.3963. Epub 2017 Feb 28. No abstract available.

16.

Microbiome: the beginning of understanding. Dr. Paul Moayyedi in an interview with Dr. Roman Jaeschke: part 1.

Moayyedi P, Jaeschke R.

Pol Arch Intern Med. 2017 Feb 28;127(2):135-136. doi: 10.20452/pamw.3961. Epub 2017 Feb 28. No abstract available.

17.

Cystic fibrosis: past, present, future. Dr. Andreas Freitag in an interview with Dr. Roman Jaeschke.

Freitag A, Jaeschke R.

Pol Arch Intern Med. 2017 Jan 31;127(1):73-75. doi: 10.20452/pamw.3922. Epub 2017 Jan 31. No abstract available.

18.

HOPE-‑3, BP treatment, milestones in CV prevention. Dr. Salim Yusuf in an interview with Dr. Akbar Panju and Dr. Roman Jaeschke.

Yusuf S, Panju A, Jaeschke R.

Pol Arch Med Wewn. 2016 Dec 23;126(12):1033-1035. doi: 10.20452/pamw.3765. Epub 2016 Dec 22. No abstract available.

19.

Treatment of asthma: predicting the future of atopic disease treatment Dr. Paul O'Byrne in an interview with Dr. Roman Jaeschke: part 2.

O'Byrne P, Jaeschke R.

Pol Arch Med Wewn. 2016 Dec 23;126(12):1031-1032. doi: 10.20452/pamw.3763. Epub 2016 Dec 22. No abstract available.

20.

Treatment of asthma: roles of different classes of drugs Dr. Paul O'Byrne in an interview with Dr. Roman Jaeschke: part 1.

O'Byrne P, Jaeschke R.

Pol Arch Med Wewn. 2016 Dec 23;126(12):1028-1030. doi: 10.20452/pamw.3761. Epub 2016 Dec 22. No abstract available.

21.

VTE treatment in 201 6 and future challenges Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 3.

Crowther M, Jaeschke R.

Pol Arch Med Wewn. 2016 Dec 23;126(12):1026-1027. doi: 10.20452/pamw.3780. Epub 2016 Dec 22. No abstract available.

22.

Milestones in VTE treatment. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 2.

Crowther M, Jaeschke R.

Pol Arch Med Wewn. 2016 Dec 23;126(12):1025. doi: 10.20452/pamw.3778. Epub 2016 Dec 22. No abstract available.

23.

2015 in hematology and thromboembolism. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 1.

Crowther M, Jaeschke R.

Pol Arch Med Wewn. 2016 Dec 23;126(12):1024. doi: 10.20452/pamw.3776. Epub 2016 Dec 22. No abstract available.

24.

Safety of long‑acting ß2‑agonists: current state of knowledge. Dr. Paul O'Byrne in an interview with Dr. Roman Jaeschke: part 2.

O'Byrne P, Jaeschke R.

Pol Arch Med Wewn. 2016 Nov 30;126(11):912-913. doi: 10.20452/pamw.3669. Epub 2016 Nov 30. No abstract available.

25.

Safety of long-‑acting β2-‑agonists: a little bit of history. Dr. Paul O'Byrne in an interview with Dr. Roman Jaeschke: part 1.

O'Byrne P, Jaeschke R.

Pol Arch Med Wewn. 2016 Nov 30;126(11):910-911. doi: 10.20452/pamw.3667. Epub 2016 Nov 30. No abstract available.

26.

Aspirin in prevention of cardiovascular events. Dr. Gordon Guyatt in an interview with Dr. Roman Jaeschke.

Guyatt G, Jaeschke R.

Pol Arch Med Wewn. 2016 Nov 30;126(11):909. doi: 10.20452/pamw.3665. Epub 2016 Nov 30. No abstract available.

27.

Drugs in diabetes in 2016, changes in endocrinology in 2015. Dr. Hertzel Gerstein in an interview with Dr. Roman Jaeschke.

Gerstein H, Jaeschke R.

Pol Arch Med Wewn. 2016 Nov 30;126(11):907-908. doi: 10.20452/pamw.3663. Epub 2016 Nov 30. No abstract available.

28.

SPRINT trial and blood pressure treatment. Dr. Gordon Guyatt in an interview with Dr. Roman Jaeschke.

Guyatt G, Jaeschke R.

Pol Arch Med Wewn. 2016 Oct 28;126(10):806-807. doi: 10.20452/pamw.3614. Epub 2016 Oct 28. No abstract available.

29.

Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes mellitus. Dr. Hertzel Gerstein in an interview with Dr. Roman Jaeschke.

Gerstein H, Jaeschke R.

Pol Arch Med Wewn. 2016 Oct 28;126(10):803-805. doi: 10.20452/pamw.3612. Epub 2016 Oct 28. No abstract available.

30.

Periprocedural risk of bleeding and thrombosis: to bridge or not to bridge. Dr. James Douketis in an interview with Dr. Roman Jaeschke: part 2.

Douketis J, Jaeschke R.

Pol Arch Med Wewn. 2016 Oct 28;126(10):801-802. doi: 10.20452/pamw.3610. Epub 2016 Oct 28. No abstract available.

31.

BRIDGE trial. Dr. James Douketis in an interview with Dr. Roman Jaeschke: part 1.

Douketis J, Jaeschke R.

Pol Arch Med Wewn. 2016 Oct 28;126(10):798-800. doi: 10.20452/pamw.3608. Epub 2016 Oct 28. No abstract available.

32.

Stress ulcer prophylaxis in critical care: a 2016 perspective Dr. Waleed Alhazzani in an interview with Dr. Roman Jaeschke: part 2.

Alhazzani W, Jaeschke R.

Pol Arch Med Wewn. 2016 Oct 30;126(10):796-797. doi: 10.20452/pamw.3606. Epub 2016 Oct 28. No abstract available.

33.

Resuscitation in sepsis in 2016. What's new? Dr. Waleed Alhazzani in an interview with Dr. Roman Jaeschke: part 1.

Alhazzani W, Jaeschke R.

Pol Arch Med Wewn. 2016 Oct 28;126(10):794-795. doi: 10.20452/pamw.3604. Epub 2016 Oct 28. No abstract available.

34.

Do not consider amiodarone, give it! Comment on antiarrhythmic drugs for shock‑refractory ventricular fibrillation or pulseless ventricular tachycardia.

Gibson AE, Jaeschke R.

Pol Arch Med Wewn. 2016 Oct 28;126(10):791-792. doi: 10.20452/pamw.3602. Epub 2016 Oct 28. No abstract available.

35.

Od danych naukowych do praktycznych zaleceń - tworzenie wytycznych według metodologii GRADE.

Leśniak W, Bała MM, Jaeschke R, Brożek JL.

Pol Arch Med Wewn. 2015 Dec 22;125 Spec No.:26-41. Review. Polish. No abstract available.

36.

Proces przygotowywania przeglądów systematycznych, z uwzględnieniem przeglądów Cochrane.

Bała MM, Leśniak W, Jaeschke R.

Pol Arch Med Wewn. 2015 Dec 22;125 Spec No.:16-25. Review. Polish. No abstract available.

37.

Cochrane Collaboration w Polsce

Bała MM, Leśniak W, Jaeschke R.

Pol Arch Med Wewn. 2015 Dec 22;125 Spec No.:5-15. Review. Polish. No abstract available.

38.

Methodological background and strategy for the 2012-2013 updated consensus definitions and clinical practice guidelines from the abdominal compartment society.

Kirkpatrick AW, Roberts DJ, Jaeschke R, De Waele JJ, De Keulenaer BL, Duchesne J, Bjorck M, Leppäniemi A, Ejike JC, Sugrue M, Cheatham ML, Ivatury R, Ball CG, Reintam Blaser A, Regli A, Balogh Z, D'Amours S, De Laet I, Malbrain ML.

Anaesthesiol Intensive Ther. 2015;47 Spec No:s63-77. doi: 10.5603/AIT.a2015.0081. Epub 2015 Nov 20. Review.

PMID:
26588481
39.

Comment on "Our prescription drugs kill us in large numbers".

Jaeschke R.

Pol Arch Med Wewn. 2015;125(1-2):105-6. No abstract available.

40.

Albumin administration in patients with sepsis--response.

Rochwerg B, Alhazzani W, Jaeschke R, Cook DJ.

Ann Intern Med. 2015 Feb 17;162(4):319-20. doi: 10.7326/L15-5051-2. No abstract available.

PMID:
25686174
41.

Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine.

Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, Jaeschke R, Mebazaa A, Pinsky MR, Teboul JL, Vincent JL, Rhodes A.

Intensive Care Med. 2014 Dec;40(12):1795-815. doi: 10.1007/s00134-014-3525-z. Epub 2014 Nov 13.

42.

Fluid resuscitation in sepsis: a systematic review and network meta-analysis.

Rochwerg B, Alhazzani W, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, Mbuagbaw L, Szczeklik W, Alshamsi F, Altayyar S, Ip WC, Li G, Wang M, Wludarczyk A, Zhou Q, Guyatt GH, Cook DJ, Jaeschke R, Annane D; Fluids in Sepsis and Septic Shock Group.

Ann Intern Med. 2014 Sep 2;161(5):347-55. doi: 10.7326/M14-0178. Review.

PMID:
25047428
43.

How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature.

Murad MH, Montori VM, Ioannidis JP, Jaeschke R, Devereaux PJ, Prasad K, Neumann I, Carrasco-Labra A, Agoritsas T, Hatala R, Meade MO, Wyer P, Cook DJ, Guyatt G.

JAMA. 2014 Jul;312(2):171-9. doi: 10.1001/jama.2014.5559.

PMID:
25005654
44.

Hemicraniectomy for middle-cerebral-artery stroke.

Jaeschke R.

N Engl J Med. 2014 Jun 12;370(24):2347. doi: 10.1056/NEJMc1404585. No abstract available.

PMID:
24918382
45.

Digitalis for treatment of heart failure in patients in sinus rhythm.

Hood WB Jr, Dans AL, Guyatt GH, Jaeschke R, McMurray JJ.

Cochrane Database Syst Rev. 2014 Apr 28;(4):CD002901. doi: 10.1002/14651858.CD002901.pub3. Review.

PMID:
24771511
46.

Clinical meaning of the GRADE rules.

Rochwerg B, Alhazzani W, Jaeschke R.

Intensive Care Med. 2014 Jun;40(6):877-9. doi: 10.1007/s00134-014-3273-0. Epub 2014 Mar 26. No abstract available.

PMID:
24667920
47.

Letter reply to GRADE guidelines articles 14 and 15.

Guyatt G, Montori V, Schunemann H, Alonso-Coello P, Dahm P, Brito Campana JP, Brozek J, Nasser M, Meerpohl J, Rind D, Jaeschke R, Fack-Ytter Y, Norris S.

J Clin Epidemiol. 2014 Feb;67(2):240. doi: 10.1016/j.jclinepi.2013.09.016. No abstract available.

PMID:
24377386
48.

The authors reply.

Dellinger RP, Jaeschke R.

Crit Care Med. 2013 Dec;41(12):e487. doi: 10.1097/CCM.0000000000000055. No abstract available.

PMID:
24275419
49.

The authors reply.

Annane D, Jaeschke R, Dellinger RP.

Crit Care Med. 2013 Dec;41(12):e483. doi: 10.1097/CCM.0000000000000014. No abstract available.

PMID:
24275411
50.

The authors reply.

Alhazzani W, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ.

Crit Care Med. 2013 Nov;41(11):e397-8. doi: 10.1097/CCM.0b013e3182a42e5d. No abstract available.

PMID:
24162705

Supplemental Content

Loading ...
Support Center